Honghua Extract Mediated Potent Inhibition of COVID-19 Host Cell Pathways
Authors
Affiliations
Honghua (Carthami flos) and Xihonghua (Croci stigma) have been used in anti-COVID-19 as Traditional Chinese Medicine, but the mechanism is unclear. In this study, we applied network pharmacology by analysis of active compounds and compound-targets networks, enzyme kinetics assay, signaling pathway analysis and investigated the potential mechanisms of anti-COVID-19. We found that both herbs act on signaling including kinases, response to inflammation and virus. Moreover, crocin likely has an antiviral effect due to its high affinity towards the human ACE2 receptor by simulation. The extract of Honghua and Xihonghua exhibited nanozyme/herbzyme activity of alkaline phosphatase, with distinct fluorescence. Thus, our data suggest the great potential of Honghua in the development of anti-COVID-19 agents.
Zhao J, Alimu A, Li Y, Lin Z, Li J, Wang X Pharmaceuticals (Basel). 2024; 17(10).
PMID: 39458990 PMC: 11510286. DOI: 10.3390/ph17101349.
Wu G, Ren Z, Hao Q, Wong Y, Zha D, Cao X Medicine (Baltimore). 2024; 103(7):e36837.
PMID: 38363944 PMC: 10869077. DOI: 10.1097/MD.0000000000036837.
Abudureyimu M, Yang M, Wang X, Luo X, Ge J, Peng H Front Med. 2023; 17(6):1219-1235.
PMID: 37656418 DOI: 10.1007/s11684-023-0983-0.
Potential herb‒drug interactions between anti-COVID-19 drugs and traditional Chinese medicine.
Ye L, Fan S, Zhao P, Wu C, Liu M, Hu S Acta Pharm Sin B. 2023; .
PMID: 37360014 PMC: 10239737. DOI: 10.1016/j.apsb.2023.06.001.